Clinical trial targets worst side-effects of chemo

Clinical trial targets worst side-effects of chemo

Wednesday, 18 July 2018, 3:17 pmPress Release: NZ Breast Cancer Foundation July 18, 2018 Clinical trial targets worst side-effects of breast cancer chemo Breast Cancer Foundation NZ has committed $250,000 to a new clinical trial that will test the ability of a cheap, widely available drug to prevent two of chemotherapy’s most unpleasant side-effects: delayed […]

Tufts: Clinical trials face tough going as data densities grow

Tufts: Clinical trials face tough going as data densities grow

By Marie PowersNews Editor Clinical trial protocols have grown ever more complex, and that craving to capture larger and more diverse data points has begun to affect the efficiency of therapeutic development, according to an analysis by the Tufts Center for the Study of Drug Development (CSDD). “At a macro level, every measure of complexity […]

Global Gall Stone Market – Ongoing Clinical Trials Analysis & Outlook to 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–Jul 17, 2018–The “Gall Stone Ongoing Global Clinical Trials Analysis and Outlook” report has been added to ResearchAndMarkets.com‘s offering. Gall Stone ongoing clinical trials report provides comprehensive analysis and trends in global Gall Stone disease clinical trials. The research work analyzes the ongoing Gall Stone clinical trial trends across countries and companies. The report […]

China's new Alzheimer's drug completes phase 3 clinical trial

A Chinese research group on Tuesday announced progress in developing a drug to treat Alzheimer’s disease. GV-971 was developed by Ocean University of China, Shanghai Institute of Materia Medica under Chinese Academy of Sciences and Green Valley Pharmaceutical Co., Ltd, after a 21-year study. A phase three clinical trial is the last test before reaching […]

Tegsedi Found to Improve Neuropathy Symptoms, Quality of Life in FAP Patients in Phase 3 Trial

Tegsedi Found to Improve Neuropathy Symptoms, Quality of Life in FAP Patients in Phase 3 Trial

Treatment with the investigative therapy Tegsedi (inotersen) provides early and significant improvements in neuropathy symptoms and quality of life in patients with familial amyloid polyneuropathy (FAP), according to results from a pivotal Phase 2/3 clinical trial. These results, announced by Ionis Pharmaceuticals, the treatment’s developer, and its affiliate, Akcea Therapeutics, were published in the study, “Inotersen Treatment for Patients […]

Health Canada is ordered to provide clinical trial data on several vaccines to a researcher

Health Canada is ordered to provide clinical trial data on several vaccines to a researcher

A Canadian judge has ruled that Health Canada must provide a University of Maryland researcher with clinical trial data for various medicines, a move that may increase efforts to independently verify studies used to win regulatory approval for prescription drugs. In a 43-page ruling last week, the judge decided that Health Canada failed to follow […]

FDA outlines renewed efforts to include older adults in clinical trials

FDA outlines renewed efforts to include older adults in clinical trials

With any clinical trial, Jacqueline Corrigan-Curay, director, Office of Medical Policy at the US Food and Drug Administration (FDA), said researchers must carefully assess if the benefits of enrolling a particular participant in a study outweigh the potential risks. In geriatric trials, however, there may be additional risks due to comorbidities and concomitant medications that […]

BMJ paper calls for more regulatory coordination in the Americas to improve clinical trial transparency

BMJ paper calls for more regulatory coordination in the Americas to improve clinical trial transparency

A new paper published in the BMJ by co-authors Trudo Lemmens and Carlos Herrera Vacaflor calls for more coordination between regulatory agencies in the Americas despite recent initiatives designed to improve health data transparency in clinical trials. In the paper, Lemmens and Vacaflor argue that government health agencies involved in health-related research should both coordinate and […]